Drug Shortage Report for MAXIDEX

Last updated on 2019-02-05 History
Report ID 59391
Drug Identification Number 00042579
Brand name MAXIDEX
Common or Proper name MAXIDEX OINTMENT 3.5MG
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) DEXAMETHASONE
Strength(s) 0.1%
Dosage form(s) OINTMENT
Route of administration OPHTHALMIC
Packaging size 3.5MG
ATC code S01BA
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-09-10
Actual start date 2018-09-10
Estimated end date 2019-02-04
Actual end date 2019-02-04
Shortage status Resolved
Updated date 2019-02-05
Company comments Maxidex 0.1% Suspension 5ml is available (#742021)
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v33 2019-02-05 English Compare
v32 2019-02-04 French Compare
v31 2019-02-04 English Compare
v30 2019-02-01 French Compare
v29 2019-02-01 English Compare
v28 2019-01-30 French Compare
v27 2019-01-30 English Compare
v26 2019-01-25 French Compare
v25 2019-01-25 English Compare
v24 2019-01-09 French Compare
v23 2019-01-09 English Compare
v22 2018-11-23 French Compare
v21 2018-11-23 English Compare
v20 2018-11-16 French Compare
v19 2018-11-16 English Compare
v18 2018-11-01 French Compare
v17 2018-11-01 English Compare
v16 2018-10-23 French Compare
v15 2018-10-23 English Compare
v14 2018-10-17 French Compare

Showing 1 to 20 of 33